MSA
SLXP

Mason Street Advisors’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Mason Street Advisors’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-25,665
Closed -$4.43M – 1532
2015
Q1 		$4.43M Sell
25,665
-250,787
-91% -$36.8M 0.13% 149
2014
Q4 		$31.8M Buy
276,452
+121,432
+78% +$14.7M 0.22% 97
2014
Q3 		$24.2M Sell
155,020
-103,032
-40% -$14.9M 0.19% 121
2014
Q2 		$31.8M Buy
258,052
+95,347
+59% +$10.5M 0.25% 80
2014
Q1 		$16.9M Buy
162,705
+31,459
+24% +$3.22M 0.14% 196
2013
Q4 		$11.8M Buy
131,246
+35,136
+37% +$2.8M 0.1% 259
2013
Q3 		$6.43M Buy
96,110
+76,860
+399% +$5.3M 0.07% 297
2013
Q2 		$1.27M Buy
+19,250
New +$1.1M 0.01% 834

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Mason Street Advisors's SLXP Position: Q2 2015 in Review

Mason Street Advisors sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 25,665 shares — an estimated $4.43M sold.

Mason Street Advisors first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $31.8M in Q2 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Mason Street Advisors reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Mason Street Advisors sold 25,665 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $4.43M.
  • Mason Street Advisors first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Mason Street Advisors's SALIX PHARMACEUTICALS LTD DEL position peaked at $31.8M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Mason Street Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.